Ani Pharmaceuticals (ANIP) Operating Margin Growth (3y) (2015 - 2026)
Powered by 
Analysis
Ani Pharmaceuticals (ANIP) Operating Margin Growth (3y) (2015 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.81 Bn | 39.16 Bn | 2.15 Bn | 1,129.00 |
| 2 | Viatris | 19.17 Bn | 18.28 Bn | 1.46 Bn | -925.00 |
| 3 | Dr Reddys Laboratories | 9.90 Bn | 9.73 Bn | 396.53 Mn | -2,128.00 |
| 4 | Amneal Pharmaceuticals | 5.47 Bn | 5.35 Bn | 334.51 Mn | 293.00 |
| 5 | Bausch Health Companies | 2.32 Bn | 479.50 Mn | 2.10 Bn | 693.00 |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn | -230,408.00 |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.12 Bn | 165.89 Mn | 457.00 |
| 8 | Amphastar Pharmaceuticals | 997.70 Mn | 707.58 Mn | 93.47 Mn | -372.00 |
| 9 | Fennec Pharmaceuticals | 395.89 Mn | 354.64 Mn | 17.15 Mn | 15,005.00 |
| 10 | RedHill Biopharma | 179.21 Mn | 179.21 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 457.00 |
| Mar 31, 2026 | 711.00 |
| Dec 31, 2025 | 1,214.00 |
| Sep 30, 2025 | 2,187.00 |
| Jun 30, 2025 | 2,406.00 |
| Mar 31, 2025 | 4,306.00 |
| Dec 31, 2024 | 3,664.00 |
| Sep 30, 2024 | -699.00 |
| Jun 30, 2024 | 3,573.00 |
| Mar 31, 2024 | 919.00 |
| Dec 31, 2023 | 453.00 |
| Sep 30, 2023 | 833.00 |
| Jun 30, 2023 | 3,397.00 |
| Mar 31, 2023 | 2,502.00 |
| Dec 31, 2022 | 1,167.00 |
| Sep 30, 2022 | -2,023.00 |
| Jun 30, 2022 | -3,458.00 |
| Mar 31, 2022 | -3,809.00 |
| Dec 31, 2021 | -5,897.00 |
| Sep 30, 2021 | -2,679.00 |